Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Colorectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Heart Defects, Congenital 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 35Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 16Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × Enhanced Recovery After Surgery × Clear all
NCT07328633 2026-01-09

Prehabilitation Plus ERAS in Gastric Cancer Surgery

The Affiliated Hospital of Qingdao University

Phase NA Completed
136 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06365814 2024-04-15

ERAS for Gastric Cancer Patients After NACT

The Affiliated Hospital of Qingdao University

Completed
252 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01653496 2016-02-02

ERAS

Chonnam National University Hospital

Phase 2 Completed
168 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡